Does Aronia Cardiometabolic Markers Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Aronia Cardiometabolic Markers Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - However, the evidence from randomized controlled trials (RCTs) remains inconclusive. [Frumuzachi O (2025); evidence level 1] - RCTs investigating chokeberry supplementation (≥2 weeks) in adults (≥18 years) with or without cardiometabolic risk factors were included. [Frumuzachi O (2025); evidence level 1] - Heterogeneity was assessed using the I 2 statistic, and risk of bias was evaluated with the Cochrane risk of bias 1 (RoB 1) tool. [Frumuzachi O (2025); evidence level 1] - Background/Objectives : Chokeberry ( Aronia melanocarpa (Michx.) Elliott) is a (poly)phenol-rich fruit with purported cardiometabolic benefits. [Frumuzachi O (2025); evidence level 1] - Background: Chokeberries (Aronia spp.) are known to exhibit both direct and indirect antioxidant properties and have been associated with beneficial effects on human health, including cardiovascular risk factors (inflammation, serum lipids, sugars, blood pressure), oxidative stress, and semen quality. [Sangild J (2023); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.